These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 12650071)
21. Is homocysteine toxic in uremia? Perna AF; Luciano MG; Pulzella P; Satta E; Capasso R; Lombardi C; Ingrosso D; De Santo NG J Ren Nutr; 2008 Jan; 18(1):12-7. PubMed ID: 18089438 [TBL] [Abstract][Full Text] [Related]
22. Pathophysiology and clinical importance of hyperhomocysteinemia: clinical intervention studies. Sunder-Plassmann G; Födinger M Miner Electrolyte Metab; 1999; 25(4-6):286-90. PubMed ID: 10681653 [TBL] [Abstract][Full Text] [Related]
23. Metabolism of homocysteine and its relationship with cardiovascular disease. Aguilar B; Rojas JC; Collados MT J Thromb Thrombolysis; 2004 Oct; 18(2):75-87. PubMed ID: 15789174 [TBL] [Abstract][Full Text] [Related]
24. [Study of the effect of medicinal product "STRESSEN" on blood levels of homocysteine in patients with current cardiovascular disease]. Bovenzi F Clin Ter; 2004 Jan; 155(1):13-5. PubMed ID: 15147075 [TBL] [Abstract][Full Text] [Related]
25. Hyperhomocysteinemia in renal diseases. Ferechide D; Radulescu D J Med Life; 2009; 2(1):53-9. PubMed ID: 20108491 [TBL] [Abstract][Full Text] [Related]
26. Coronary artery disease and homocysteine: a case study. Shinnick MA; Holmes LI Am J Crit Care; 1999 May; 8(3):193-6. PubMed ID: 10228661 [No Abstract] [Full Text] [Related]
27. [Hyperhomocysteinemia hastens myocardial infarct and stroke. Prevention.with leaf salads and vitamins]. Meissner T MMW Fortschr Med; 2003 Mar; 145(10):10. PubMed ID: 12688018 [No Abstract] [Full Text] [Related]
30. [Hyperhomocysteinemia and the disturbance of haemostasis--facts and mythes]. Malinowska J; Nowak P; Olas B Pol Merkur Lekarski; 2009 Nov; 27(161):413-8. PubMed ID: 19999808 [TBL] [Abstract][Full Text] [Related]
31. Homocysteine gets to the brain. Sela BA Isr Med Assoc J; 2002 Mar; 4(3):204-6. PubMed ID: 11908265 [No Abstract] [Full Text] [Related]
32. The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins. Siragusa S; Malato A; Cigna V; Anastasio R; Coco LL; Casuccio A; Ciaccio M Thromb Res; 2007; 121(1):51-3. PubMed ID: 17462714 [No Abstract] [Full Text] [Related]
33. [Homocysteine as a coronary risk factor]. Derbeneva SA; Pogozheva AV Vopr Pitan; 2003; 72(5):43-8. PubMed ID: 14619617 [TBL] [Abstract][Full Text] [Related]
34. No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia. Spoelstra-de MA; Brouwer CB; Terheggen F; Bollen JM; Stehouwer CD; Smulders YM Neth J Med; 2004; 62(7):246-53. PubMed ID: 15554600 [TBL] [Abstract][Full Text] [Related]
35. Homocysteine and the heart. Turner SL; Bechtel GA Adv Nurse Pract; 1999 Mar; 7(3):71-3. PubMed ID: 10373803 [No Abstract] [Full Text] [Related]
36. Randomized clinical trial of homocysteine level lowering therapy and fractures. Sawka AM; Ray JG; Yi Q; Josse RG; Lonn E Arch Intern Med; 2007 Oct; 167(19):2136-9. PubMed ID: 17954810 [No Abstract] [Full Text] [Related]
37. Homocysteine is not so paradoxical. Klevay LM Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):e160; author reply e161. PubMed ID: 18799792 [No Abstract] [Full Text] [Related]